Edition:
India

Egalet Corp (EGLT.OQ)

EGLT.OQ on NASDAQ Stock Exchange Global Market

1.00USD
17 Nov 2017
Change (% chg)

$-0.14 (-12.61%)
Prev Close
$1.15
Open
$1.29
Day's High
$1.30
Day's Low
$0.95
Volume
1,389,793
Avg. Vol
114,293
52-wk High
$10.00
52-wk Low
$0.80

Select another date:

Fri, Nov 17 2017

BRIEF-EGALET ANNOUNCES LATE-STAGE STUDY DATA ON EGALET-002

* EGALET ANNOUNCES POSITIVE TOP-LINE RESULTS FROM PHASE 3 SAFETY STUDY EVALUATING SAFETY OF EGALET-002

BRIEF-Egalet announces ARYMO ER added to large payer Medicare Part D Formulary

* A large payer will provide coverage of ARYMO ER extended-release tablets for oral use -CII for its Medicare Part D Members​

BRIEF-Highbridge Capital Management LLC reports 9.58 pct passive stake in Egalet Corp as of July 6 - SEC filing

* Highbridge Capital Management LLC reports a 9.58 percent passive stake in Egalet Corp as of July 6, 2017 - SEC filing Source text: (http://bit.ly/2u2N9mR) Further company coverage:

BRIEF-Egalet announces pricing of public offering of common stock and warrants

* Egalet announces pricing of public offering of common stock and warrants

BRIEF-Egalet receives complete response letter from US FDA for prior approval supplement for 10 mg and 15 mg dosage strengths of oxaydo

* Egalet receives complete response letter from U.S. Food and Drug Administration for prior approval supplement for 10 mg and 15 mg dosage strengths of Oxaydo

BRIEF-Egalet partners with Ascend Therapeutics to co-promote Sprix nasal spray

* Egalet partners with Ascend Therapeutics® U.S., LLC to co-promote sprix® nasal spray

BRIEF-Egalet announces results of ARYMO ER harm reduction modeling analysis

* Egalet announces results of ARYMO ER harm reduction modeling analysis

Select another date: